Pharma channel feed – Endpoints News

Pharma channel feed

AbbVie buys Third Rock's Celsius for $250M to expand IBD pipeline

11 months ago

AbbVie and Genmab score accelerated follicular lymphoma nod for Epkinly

11 months ago

FDA rejects Daiichi Sankyo's HER3 ADC, a blow to quick approval plans for Merck partnership

11 months ago

FDA approves new COPD drug from Verona Pharma

11 months ago

Updated: CDC expands RSV vaccine recommendations, namely for adults 75 and older

11 months ago

Haleon to sell nicotine replacement therapy business to Dr. Reddy’s for $630M

11 months ago

Optum Rx may enter biosimilar market to match competitors CVS, Express Scripts

11 months ago

HHS reveals 64 drugs up for Medicare inflation rebates next quarter

11 months ago

EMA calls for member states to lend a hand to ease GLP-1 supply bottlenecks

11 months ago

Novo Nordisk takes $816M writedown after Phase 3 fail in chronic kidney disease

11 months ago

Moderna's updated RSV vaccine disappoints with only 50% efficacy

11 months ago

Arrowhead shelves one cardiometabolic drug candidate, focuses on another

11 months ago

Lilly becomes the latest pharma to tap OpenAI for help, this time for antibiotic work

11 months ago

Q&A: FDA medical policy chief talks decentralized trial guidance, improving diversity

11 months ago

Amgen calls Colorado's price controls on Enbrel 'unconstitutional'

11 months ago

Teva to pay $750M to resolve Israel tax disputes

11 months ago

Ginkgo to cut at least 35% of staff in multi-year restructuring plan

11 months ago

FDA again rejects AbbVie's continuous infusion therapy for Parkinson's

11 months ago

J&J's Tremfya fails giant cell arteritis study, where Roche and AbbVie have succeeded

11 months ago

Korea-based Bridge Biotherapeutics closes Boston office

11 months ago

Phase 3 breast cancer failure leads to staff cuts, stock drop at G1 Therapeutics

11 months ago

UK taps Pfizer over hometown GSK to supply RSV vaccine doses

11 months ago

Argenx wins second FDA approval for Vyvgart in autoimmune nerve disease

11 months ago

Peter Marks single-handedly approved Sarepta’s gene therapy — what does that mean for everyone else?

11 months ago

First page Previous page 49 50 515253 54 55 Next page Last page